Schultz CR - Search Results

1

Synergistic drug combination GC7/DFMO suppresses hypusine/spermidine-dependent eIF5A activation and induces apoptotic cell death in neuroblastoma.

Schultz CR, Geerts D, Mooney M, El-Khawaja R, Koster J, Bachmann AS. Schultz CR, et al. Biochem J. 2018 Jan 31;475(2):531-545. doi: 10.1042/BCJ20170597. Biochem J. 2018. PMID: 29295892

2

Ornithine decarboxylase as a therapeutic target for endometrial cancer.

Kim HI, Schultz CR, Buras AL, Friedman E, Fedorko A, Seamon L, Chandramouli GVR, Maxwell GL, Bachmann AS, Risinger JI. Kim HI, et al. Among authors: schultz cr. PLoS One. 2017 Dec 14;12(12):e0189044. doi: 10.1371/journal.pone.0189044. eCollection 2017. PLoS One. 2017. PMID: 29240775 Free PMC article.

3

Immunoproteasome inhibition and bioactivity of thiasyrbactins.

Bakas NA, Schultz CR, Yco LP, Roberts CC, Chang CA, Bachmann AS, Pirrung MC. Bakas NA, et al. Among authors: schultz cr. Bioorg Med Chem. 2018 Jan 15;26(2):401-412. doi: 10.1016/j.bmc.2017.11.048. Epub 2017 Dec 7. Bioorg Med Chem. 2018. PMID: 29269255 Free PMC article.

4

Harmine, a dual-specificity tyrosine phosphorylation-regulated kinase (DYRK) inhibitor induces caspase-mediated apoptosis in neuroblastoma.

Uhl KL, Schultz CR, Geerts D, Bachmann AS. Uhl KL, et al. Among authors: schultz cr. Cancer Cell Int. 2018 Jun 7;18:82. doi: 10.1186/s12935-018-0574-3. eCollection 2018. Cancer Cell Int. 2018. PMID: 29977157 Free PMC article.

5

Polyamine Biosynthetic Pathway as a Drug Target for Osteosarcoma Therapy.

Weicht RR, Schultz CR, Geerts D, Uhl KL, Bachmann AS. Weicht RR, et al. Among authors: schultz cr. Med Sci (Basel). 2018 Aug 16;6(3):65. doi: 10.3390/medsci6030065. Med Sci (Basel). 2018. PMID: 30115881 Free PMC article.

6

Novel de novo pathogenic variant in the ODC1 gene in a girl with developmental delay, alopecia, and dysmorphic features.

Bupp CP, Schultz CR, Uhl KL, Rajasekaran S, Bachmann AS. Bupp CP, et al. Among authors: schultz cr. Am J Med Genet A. 2018 Dec;176(12):2548-2553. doi: 10.1002/ajmg.a.40523. Epub 2018 Sep 21. Am J Med Genet A. 2018. PMID: 30239107

7

Biochemical features of primary cells from a pediatric patient with a gain-of-function ODC1 genetic mutation.

Schultz CR, Bupp CP, Rajasekaran S, Bachmann AS. Schultz CR, et al. Biochem J. 2019 Jul 24;476(14):2047-2057. doi: 10.1042/BCJ20190294. Biochem J. 2019. PMID: 31249027

8

Allicin, a Potent New Ornithine Decarboxylase Inhibitor in Neuroblastoma Cells.

Schultz CR, Gruhlke MCH, Slusarenko AJ, Bachmann AS. Schultz CR, et al. J Nat Prod. 2020 Aug 28;83(8):2518-2527. doi: 10.1021/acs.jnatprod.0c00613. Epub 2020 Aug 12. J Nat Prod. 2020. PMID: 32786875 Free PMC article.

9

Emerging Role of ODC1 in Neurodevelopmental Disorders and Brain Development.

Prokop JW, Bupp CP, Frisch A, Bilinovich SM, Campbell DB, Vogt D, Schultz CR, Uhl KL, VanSickle E, Rajasekaran S, Bachmann AS. Prokop JW, et al. Among authors: schultz cr. Genes (Basel). 2021 Mar 25;12(4):470. doi: 10.3390/genes12040470. Genes (Basel). 2021. PMID: 33806076 Free PMC article.

10

Probenecid increases renal retention and antitumor activity of DFMO in neuroblastoma.

Schultz CR, Swanson MA, Dowling TC, Bachmann AS. Schultz CR, et al. Cancer Chemother Pharmacol. 2021 Oct;88(4):607-617. doi: 10.1007/s00280-021-04309-y. Epub 2021 Jun 15. Cancer Chemother Pharmacol. 2021. PMID: 34129075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters